 |
| Research Gate |
Every
other major Southeast Asian market found a way to list companies in the
first half of 2026. Malaysia listed 36. Vietnam went from zero to four
and posted the region's single highest IPO market capitalization at 6.93
billion dollars. Even Singapore, a market most people associate with
size rather than volume, put up five listings worth 1.51 billion
dollars, more than 25 times what it managed a year earlier. The
Philippines listed nothing. Zero IPOs. Zero dollars in market
capitalization. The only line on this entire chart that reads exactly
zero.
This did not happen because the Philippine economy was uniquely weak relative to its neighbors in the first half of 2026, though the 2.3 percent Q2 GDP print we covered in our earlier deep dive certainly did not help sentiment. It happened because the country's capital markets infrastructure has been unable to convert the country's economic activity into public listings at any point in 2026, a pattern that predates and is unrelated to this year's specific macro headwinds. The single Philippine IPO recorded in the same period last year, H1 2025, was a 12 million dollar listing from Top Line Business Development Corporation, a Cebu-based fuel retailer. Twelve million dollars, against Malaysia's 1.34 billion dollars in H1 2026 proceeds alone. The gap is not a rounding error. It is a structural absence.
The regional picture this chart displays is worth understanding in full before assessing what it means for the Philippines specifically, because Southeast Asia's 2026 IPO story is genuinely a good one and the Philippines' complete exclusion from it is what makes the local story worse by comparison rather than better. Deloitte's Southeast Asia Mid-Year IPO Snapshot recorded 47 IPOs across the region in H1 2026, an 11 percent decline in count from H1 2025's 53 listings, but total proceeds surged 117 percent to more than 3.07 billion dollars and aggregate market capitalization rose 96 percent to 15.07 billion dollars. The average IPO deal size expanded from 26 million dollars to 65 million dollars, roughly 2.4 times larger than a year earlier. This is not a market getting more active in a simple volume sense. It is a market getting more selective and more institutional, favoring fewer but dramatically larger and higher-quality transactions, exactly the framing Deloitte itself used to describe the shift.
Three blockbuster IPOs drove the entire regional result: UI Boustead REIT in Singapore, Sunway Healthcare Holdings Berhad in Malaysia which alone raised approximately 707 million dollars at a 4.13 billion dollar market capitalization, and Dien May Xanh Investment Joint Stock in Vietnam. Together these three listings alone generated 8.93 billion dollars in market capitalization, more than half the region's entire IPO output for the half-year, and none of them exceeded 500 million dollars in proceeds during the comparable period a year earlier, meaning zero deals of this size existed in the region as recently as H1 2025. The Southeast Asian IPO market did not simply recover in 2026. It found a new gear entirely, driven by institutional investors who are now willing to fund scale, proven operations, and credible growth stories at a size and price point that did not exist eighteen months ago.
Malaysia's leadership position is the most instructive comparison for the Philippines specifically, because the two markets share more structural similarities than Malaysia shares with Singapore or Vietnam. Malaysia is not larger than the Philippines by GDP, does not have a materially deeper pool of institutional capital, and does not benefit from the kind of unique regulatory arbitrage that makes Singapore attractive to regional listings. What Malaysia has, and what the Deloitte report specifically credits, is a strong and consistently replenished pipeline, currently more than 40 potential listings according to Bursa Malaysia's own disclosed pipeline, built on sustained investor confidence and what the report describes as growing interest in sectors with long-term growth potential. That pipeline did not appear by accident. It is the output of years of consistent regulatory engagement between the exchange, the regulator, and the corporate issuers who might eventually list, an engagement process that produces a steady supply of IPO-ready companies rather than relying on episodic mega-deals to carry the market.
We have covered extensively, across our deep dive on Mynt's pending 92.3 billion peso IPO and VITRO REIT's upcoming 24.2 billion peso listing, why the second half of 2026 should look considerably different for the PSE than the first half did. Both of those offerings, if they complete on schedule between September and October, would immediately place the Philippines among the region's larger IPO markets for the year in aggregate proceeds, potentially surpassing Malaysia's entire H1 total in two transactions alone. That is genuinely encouraging and worth taking seriously as a forward-looking signal. But it also illustrates precisely the structural problem this chart is documenting. The Philippines does not have a pipeline. It has two specific, large, well-publicized transactions that happen to be arriving in the same six-month window, following a six-month window in which the pipeline produced literally nothing. Malaysia's IPO market functions like a factory with consistent output. The Philippine IPO market functions like an occasional event, dependent on whichever single large company happens to be ready to list in any given year, with long stretches of complete dormancy in between.
The consequence of this structural difference compounds over time in ways that are not visible in any single six-month snapshot but that we have already quantified in our earlier analysis of PSE IPO performance since 2013. Of the 33 major PSE IPOs we tracked from 2013 through the present, only 8 currently trade above their offer price, a 75 percent failure rate that we attributed partly to persistent mispricing at listing and partly to a shallow secondary market that struggles to sustain valuations once the initial listing enthusiasm fades. A market that produces a genuine pipeline of listings, the way Malaysia's 40-plus potential candidates suggest a deep and continuously replenishing supply of IPO-ready companies does, develops deeper institutional coverage, more liquid secondary trading, and a broader base of comparable transactions that help price the next listing more accurately. A market that goes from zero IPOs in one half-year to two mega-deals in the next has none of that infrastructure benefit. Each Philippine IPO is priced and evaluated in relative isolation, which is precisely the dynamic that has historically produced the pricing failures documented in our IPO tracker.
The regional data also reframes how investors should think about the Mynt and VITRO REIT listings specifically. Deloitte's own forward guidance for H2 2026 anticipates the region will continue favoring fewer but larger and higher-quality transactions, supported by easing interest rate conditions and improving investor sentiment. If that regional dynamic holds, the Philippines arriving with two large, high-quality, well-capitalized offerings in September and October is not a coincidence of timing. It is the Philippines participating, for the first time in 2026, in exactly the trend that has already reshaped Malaysia, Vietnam, and Singapore's markets earlier in the year. The test for whether this represents a genuine turning point rather than another isolated event is whether a third, fourth, and fifth listing follow in 2027 and beyond, building the kind of continuously replenished pipeline that Malaysia has and the Philippines has never sustained.
Zero is a number that does not require interpretation. It is the starkest data point on this entire chart and the one every CEO of a Philippine company currently weighing a private equity exit, a family succession plan, or a capital raise should sit with directly. The region is proving, with 15.07 billion dollars in aggregate market capitalization and a 117 percent surge in proceeds, that institutional capital is available at scale for the right company at the right price. The Philippines spent the first half of 2026 not testing that thesis at all.
Not financial advice. Always do your own due diligence.
This did not happen because the Philippine economy was uniquely weak relative to its neighbors in the first half of 2026, though the 2.3 percent Q2 GDP print we covered in our earlier deep dive certainly did not help sentiment. It happened because the country's capital markets infrastructure has been unable to convert the country's economic activity into public listings at any point in 2026, a pattern that predates and is unrelated to this year's specific macro headwinds. The single Philippine IPO recorded in the same period last year, H1 2025, was a 12 million dollar listing from Top Line Business Development Corporation, a Cebu-based fuel retailer. Twelve million dollars, against Malaysia's 1.34 billion dollars in H1 2026 proceeds alone. The gap is not a rounding error. It is a structural absence.
The regional picture this chart displays is worth understanding in full before assessing what it means for the Philippines specifically, because Southeast Asia's 2026 IPO story is genuinely a good one and the Philippines' complete exclusion from it is what makes the local story worse by comparison rather than better. Deloitte's Southeast Asia Mid-Year IPO Snapshot recorded 47 IPOs across the region in H1 2026, an 11 percent decline in count from H1 2025's 53 listings, but total proceeds surged 117 percent to more than 3.07 billion dollars and aggregate market capitalization rose 96 percent to 15.07 billion dollars. The average IPO deal size expanded from 26 million dollars to 65 million dollars, roughly 2.4 times larger than a year earlier. This is not a market getting more active in a simple volume sense. It is a market getting more selective and more institutional, favoring fewer but dramatically larger and higher-quality transactions, exactly the framing Deloitte itself used to describe the shift.
Three blockbuster IPOs drove the entire regional result: UI Boustead REIT in Singapore, Sunway Healthcare Holdings Berhad in Malaysia which alone raised approximately 707 million dollars at a 4.13 billion dollar market capitalization, and Dien May Xanh Investment Joint Stock in Vietnam. Together these three listings alone generated 8.93 billion dollars in market capitalization, more than half the region's entire IPO output for the half-year, and none of them exceeded 500 million dollars in proceeds during the comparable period a year earlier, meaning zero deals of this size existed in the region as recently as H1 2025. The Southeast Asian IPO market did not simply recover in 2026. It found a new gear entirely, driven by institutional investors who are now willing to fund scale, proven operations, and credible growth stories at a size and price point that did not exist eighteen months ago.
Malaysia's leadership position is the most instructive comparison for the Philippines specifically, because the two markets share more structural similarities than Malaysia shares with Singapore or Vietnam. Malaysia is not larger than the Philippines by GDP, does not have a materially deeper pool of institutional capital, and does not benefit from the kind of unique regulatory arbitrage that makes Singapore attractive to regional listings. What Malaysia has, and what the Deloitte report specifically credits, is a strong and consistently replenished pipeline, currently more than 40 potential listings according to Bursa Malaysia's own disclosed pipeline, built on sustained investor confidence and what the report describes as growing interest in sectors with long-term growth potential. That pipeline did not appear by accident. It is the output of years of consistent regulatory engagement between the exchange, the regulator, and the corporate issuers who might eventually list, an engagement process that produces a steady supply of IPO-ready companies rather than relying on episodic mega-deals to carry the market.
We have covered extensively, across our deep dive on Mynt's pending 92.3 billion peso IPO and VITRO REIT's upcoming 24.2 billion peso listing, why the second half of 2026 should look considerably different for the PSE than the first half did. Both of those offerings, if they complete on schedule between September and October, would immediately place the Philippines among the region's larger IPO markets for the year in aggregate proceeds, potentially surpassing Malaysia's entire H1 total in two transactions alone. That is genuinely encouraging and worth taking seriously as a forward-looking signal. But it also illustrates precisely the structural problem this chart is documenting. The Philippines does not have a pipeline. It has two specific, large, well-publicized transactions that happen to be arriving in the same six-month window, following a six-month window in which the pipeline produced literally nothing. Malaysia's IPO market functions like a factory with consistent output. The Philippine IPO market functions like an occasional event, dependent on whichever single large company happens to be ready to list in any given year, with long stretches of complete dormancy in between.
The consequence of this structural difference compounds over time in ways that are not visible in any single six-month snapshot but that we have already quantified in our earlier analysis of PSE IPO performance since 2013. Of the 33 major PSE IPOs we tracked from 2013 through the present, only 8 currently trade above their offer price, a 75 percent failure rate that we attributed partly to persistent mispricing at listing and partly to a shallow secondary market that struggles to sustain valuations once the initial listing enthusiasm fades. A market that produces a genuine pipeline of listings, the way Malaysia's 40-plus potential candidates suggest a deep and continuously replenishing supply of IPO-ready companies does, develops deeper institutional coverage, more liquid secondary trading, and a broader base of comparable transactions that help price the next listing more accurately. A market that goes from zero IPOs in one half-year to two mega-deals in the next has none of that infrastructure benefit. Each Philippine IPO is priced and evaluated in relative isolation, which is precisely the dynamic that has historically produced the pricing failures documented in our IPO tracker.
The regional data also reframes how investors should think about the Mynt and VITRO REIT listings specifically. Deloitte's own forward guidance for H2 2026 anticipates the region will continue favoring fewer but larger and higher-quality transactions, supported by easing interest rate conditions and improving investor sentiment. If that regional dynamic holds, the Philippines arriving with two large, high-quality, well-capitalized offerings in September and October is not a coincidence of timing. It is the Philippines participating, for the first time in 2026, in exactly the trend that has already reshaped Malaysia, Vietnam, and Singapore's markets earlier in the year. The test for whether this represents a genuine turning point rather than another isolated event is whether a third, fourth, and fifth listing follow in 2027 and beyond, building the kind of continuously replenished pipeline that Malaysia has and the Philippines has never sustained.
Zero is a number that does not require interpretation. It is the starkest data point on this entire chart and the one every CEO of a Philippine company currently weighing a private equity exit, a family succession plan, or a capital raise should sit with directly. The region is proving, with 15.07 billion dollars in aggregate market capitalization and a 117 percent surge in proceeds, that institutional capital is available at scale for the right company at the right price. The Philippines spent the first half of 2026 not testing that thesis at all.
Not financial advice. Always do your own due diligence.
No comments:
Post a Comment